JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 31 No. 11 1823-1830
© 1990 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fink, G. D.
Right arrow Articles by Brunengraber, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fink, G. D.
Right arrow Articles by Brunengraber, H.

Metabolism of ß-Methyl-Heptadecanoic Acid in the Perfused Rat Heart and Liver

Guy D. Fink, Jane A. Montgomery, France David, Michel Garneau, Eli Livni, David Elmaleh, H. William Strauss and Henri Brunengraber

Departments of Biochemistry and Nutrition, University of Montreal, Montreal, Canada
Division of Nuclear Medicine, Massachusetts General Hospital, Boston, Massachusetts

Correspondence: For reprints contact: Henri Brunengraber, Research Center, Notre-Dame Hospital, Montreal, QC, H2L 4M1, Canada.

ABSTRACT

The metabolism of ß-methyl-[1-14C]heptadecanoic acid, a potential myocardial imaging agent, was investigated in perfused hearts and livers from rats. Hepatic uptake is ~4.5 times greater than cardiac uptake. In the heart, 66% of ß-methyl-heptadecanoic acid metabolism occurs via omega-oxidation, 33% by esterification and <1% via alpha-oxidation. In contrast, 53% of hepatic metabolism of ß-methyl-heptadecanoic acid occurs via alpha-oxidation, 27% via omega-oxidation, and 20% via esterification. Perfusion of hearts and livers with concentrations of ß-methyl-heptadecanoic acid 100 to 1000 times greater than that used for myocardial imaging does not alter any of the physiological and biochemical parameters measured. In the perfused liver, 3-methyl-[1-14C]glutarate was identified as the principal hydrosoluble catabolite of ß-methyl-heptadecanoic acid.




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
N. D. Oakes, A. Kjellstedt, G.-B. Forsberg, T. Clementz, G. Camejo, S. M. Furler, E. W. Kraegen, M. Ölwegård-Halvarsson, A. B. Jenkins, and B. Ljung
Development and initial evaluation of a novel method for assessing tissue-specific plasma free fatty acid utilization in vivo using (R)-2-bromopalmitate tracer
J. Lipid Res., June 1, 1999; 40(6): 1155 - 1169.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Yamane, N. Ishide, Y. Kagaya, D. Takeyama, N. Shiba, M. Chida, T. Nozaki, T. Takahashi, T. Ido, and K. Shirato
Heterogeneous fatty acid uptake early after reperfusion in rat hearts
Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H923 - H929.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1990 by the Society of Nuclear Medicine.